Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering not just a ...

Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

The future just got brighter, thanks to the sunshine vitamin. Scientists in Ireland have added to a growing stack of research ...

A simple nasal swab may offer an unexpected window into the earliest biological signals of Alzheimer’s disease.

The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer's Disease, or AI4AD. The new $12.6 million award to advance the project's next phase, AI4AD2, brings its ...

A UTHealth Houston physician's visit to a local public health building sparked community awareness and inspired a new ...

A proprietary monoclonal antibody targeting an inhibitory immune checkpoint pathway had favorable safety and tolerability in ...

Campbell: Welcome to "Beyond Diagnosis," where we talk with doctors about talking with patients. I'm your host, Glenn ...

House Reps. Paul Tonko (D-N.Y.) and Vern Buchanan (R-Fla.), co-sponsors of the Alzheimer’s Screening and Prevention (ASAP) ...

Older adults who received a high-dose influenza vaccine experienced a decreased risk of developing Alzheimer’s disease ...

Carolina McCalmon, a physician assistant with Novant Health Neurology Department, was in the studio to talk more about ways ...

Brain and fitness expert Rachel Daugherty shared a tip for preventing Alzheimer's that only takes a few minutes each day: ...